Google
×
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by ...
Missing: dc4618 | Show results with:dc4618
People also ask
Takeda's pipeline is diverse and dynamic, with first-in-class molecules that address areas of high unmet need. We're committed to accelerating a steady ...
Missing: dc4618 | Show results with:dc4618
The work we do transforms lives, helping patients with limited or no treatment options in our core therapeutic and business areas, ...
Missing: dc4618 | Show results with:dc4618
... TAKEDA PHARMACEUTICAL CO. LTD.,n/a,4502 JP,"86,869",n/a,n/a,"$3,660,888 ... DC,"4,618",n/a,n/a,"$567,799",0.00%,,,,, 31-Dec-2023,QSuper Lifetime Aspire 2 ...
Under the agreement, Takeda will obtain Maverick's T-cell engager COBRA™ platform and a broad development portfolio, including Maverick's lead development ...
Missing: dc4618 | Show results with:dc4618
Rating (1) · In stock
This dual rear-exit system features 4-3/4" X 4-1/4" oval black, angle-cut, stainless steel exhaust tips w/ laser-etched Takeda logo for a custom appearance.
Missing: dc4618 | Show results with:dc4618
Jan 23, 2023 · Takeda To Acquire Exclusive Worldwide (ex-China) License of HUTCHMED's Fruquintinib, a Highly Selective, Oral VEGFR1/2/3 Tyrosine Kinase ...
Missing: dc4618 | Show results with:dc4618
No information is available for this page. · Learn why
Missing: dc4618 | Show results with:dc4618
Explore our pipeline of investigational therapies for cancer treatment, including targeted therapies, proteasome inhibitors, and innate immunity enhancers.
Missing: dc4618 | Show results with:dc4618
In order to show you the most relevant results, we have omitted some entries very similar to the 10 already displayed. If you like, you can repeat the search with the omitted results included.